TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03).

Erica L Mayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.